The views expressed by contributors are their own and not the view of The Hill by Gene Baur, opinion contributor – 08/05/24 4:30 PM ET Cambridge, MA – May 14: From left, Jon Arizti Sanz, PhD, Postdoctoral Fellow with Liam Alec Stenson Ortiz, research associate working in the lab. The Broad institute, Sabeti Lab is...
Category: <span>Clinical Practice</span>
Post
Sloth Borne Virus That Has Killed People In Their 20s Rapidly Spreading In Europe
The virus is primarily spread through insect bites, including mosquitoes, and originates from pale-throated sloths, non-human primates, and birds. World NewsEdited by Anjali ThakurUpdated: August 11, 2024 10:14 pm IST Oropouche can cause symptoms such as headaches, nausea, vomiting, and muscle and joint pains A debilitating virus originating from sloths and transmitted by midges has...
Post
Low magnesium levels are linked increased disease risk, study shows
August 12, 2024 by University of South Australia Credit: Pixabay/CC0 Public DomainA new Australian study has identified why a diet rich in magnesium is so important for our health, reducing the risk of DNA damage and chronic degenerative disorders. The paper is published in the European Journal of Nutrition. Scientists from the University of South...
Post
Review suggests many men with early prostate cancer may not need lymph node removal
August 12, 2024 by Ernie Mundell For years, the treatment of early-stage prostate cancers that haven’t spread beyond the organ has often included the removal of nearby lymph nodes in the pelvis. It’s done as a precaution and as a means of “staging” the disease. Now, a major expert review on the topic suggests that,...
Post
Rheumatoid arthritis tied to higher risk for lung cancer
August 12, 2024 by Lori Solomon Rheumatoid arthritis (RA) is associated with a significantly increased risk for lung cancer, according to a study published online July 28 in Arthritis & Rheumatology. Rebecca T. Brooks, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues evaluated lung cancer risk in people with RA and RA-interstitial lung...
Post
Is Semaglutide the ‘New Statin’? Not So Fast
Medscape Diabetes & EndocrinologyCOMMENTARY Kevin Fernando, MBChB, MSc Diabetes, BSc DISCLOSURES | June 03, 2024 There has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year’s European Congress on Obesity, which led many to herald semaglutide as the “new statin.” In the SELECT CVOT, participants with...
Post
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
Pharma By Isabella Cueto Aug. 9, 2024 Neffy, the new nasal spray for severe allergic reactions, is approved for use in people 66 pounds and above.Courtesy ARS Pharma On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor from ARS...
Post
Phototherapy: How Light Is Helping Patients Heal in New Ways
Medscape Medical News Sari Harrar August 09, 2024 A surprising therapy is showing promise for chronic pain, vision loss, and muscle recovery, among other conditions. It’s not a pill, an injection, or surgery. It’s light. Yes, light. The thing that appears when you open the curtains, flip a switch, or strike a match. Light illuminates...
Post
AI Devices for Triaging Skin Cancer Have Some Hurdles to Clear
Medscape Medical News Richard Mark Kirkner August 08, 2024 Emerging diagnostic technology that uses artificial intelligence (AI) has demonstrated the potential to free dermatologists from the burden of triaging skin lesions, but dermatology lags behind some other specialties in harnessing the power of AI, and confusion surrounds dermatologists’ role in using this technology, according to...
Post
New First-Line Therapies for Migraine
Medscape Family Medicine > Clinical Guidelines for Primary CareCOMMENTARY Neil Skolnik, MD DISCLOSURES | August 07, 2024 This transcript has been edited for clarity. I’m Dr Neil Skolnik and today we are going to talk about the position statement from the American Headache Society (AHS) “Calcitonin Gene-Related Peptide-Targeting Therapies Are a First-Line Option for the...